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FBF in both groups. Arterial NOx concentration was not affected by either drug, however 
venous NOx concentrations were significantly decreased in both the control and patient 
groups by L-NMMA (18±5% and 18±17%, respectively, both p<O.05) and in the patient 
group alone by aminoguanidine (7±6%, p<0.05). The magnitude of effects of ami- 
noguanidine significantly correlated with the concentrations of BNP (r=0.63, p<O.01) and 
IL-6 (r=0.54, p<0.01 ). Acatylcholine-induced vasodilatation was atlenuated by co infusion 
of L-NMMA, but was not by aminoguanidine, suggesting the high selectivity of ami- 
noguanidine as a selective iNOS inhibitor. 
Conclusions: These findings suggested that iNOS is activated in proportion to the sever- 
ity of heart failure, associated with cytokines. 
11 51-73 Impact  of  Different Endothelial Nitric Oxide Synthsee 
Gene Polymorphisms on Endothelium-Dependent 
Vasodilation and Response to Exercise Training in 
Patients With Coronary Artery Disease 
Sandra Eros. Volker Adams, Stephan Gielen, Sven M(Sbius-Winkler, Gerhard Schuler, 
Rainer Hambrecht, University of Leipzig - Heart Center, Leipzig, Germany. 
A polymorphism of the endothelial nitric oxide synthase (eNOS) gene in exon 7 (exon7- 
P) has been well charecterized as a risk factor of coronary artery disease (CAD). An 
aNdS polymorphism in the promotor region (PR-P) was shown to alter eNOS activity. 
Aim of this study was to evaluate the impact of these polymorphisms on the extent of 
endothelial dysfunction in patients (pts) with CAD and on the endothelial response to 
exercise training (ET). 
Fifty-four CAD pts were randomised into a training (4 weeks) or an control group. Aver- 
age peak velocity (APV) in response to acetylcholine (Ach; 7.2 I~g/min) of a coronary or 
the left mammarial artery was invasively assessed by Doppler velocimetry. Exon7-P and 
PR-P were determined by PCR restriction length polymorphism. 
Twenty-six pts were heterozygous and 4 hornozygous for exon7-P (exon7-P+). A het- 
erozygous PR-P (PR-P+) occurred in 14 pts. Ach-induced increase in APV was signifi- 
cantly blunted in exon7-P+ (48±9%) and in PR-P+ (42±8%) compared to 78±9% in wild 
type pts (p<0.05). The presence of both polymorphisms (n=11) resulted in no further 
attenuation of Ach-mediated response (49±6%). 
Conclusion: The presence of the exon 7 and the promotor region eNOS polymorphism in 
CAD pts is associated with a blunted endothelial response to Ach. While exon7-P+ pts 
showed a similar favourable training response at the endothelial level compared to wild 
type pts, pts positive for the PR-P demonstrated an attenuated improvement of Ach- 
mediated vasodilation due to exercise training. 
Effects of ET on APV (* p=0.05 versus wild type and exonT-P.+; # p<0.05 versus 
begin) 
wild type exon 7 + PR + 
Delta APV begin [%] 77±131 34±9 42±8 
Delta APV 4 weeks [%] 131±21 # 87±11 # 80±12 # 
Absolute change in APV 4 weeks versus begin [%} 54±14 53±14 38±14 * 
1151-74 In Vivo Gene Transfer of eNOS and SOD Reduces 
Superoxide Formation in Angiotensin II-Treated Mice 
Hunter C. Chamoion. Trinity J. Bivalacqua, David Kass, Albert L. Hyman, Philip J. 
Kadowitz, Johns Hopkins Hospital, Baltimore, Mary~and, Tu/ane University, Baltimore, 
Maryland. 
Angiotensin It (Ang II) stimulates vascular NADPH oxidase to produce superoxide, which 
can react with nitric oxide and impair vasomotor function. We tested the hypothesis that 
the overexpression of endothelial nitric oxide synthase (eNOS) or superoxide dismutase 
(SOD) would correct angiotensin II-inducad endothelial dysfunction in the hindlimb vas- 
cular bed of the mouse in vivo. We examined the effects of the gene transfer of eNOS or 
2 isoforms of SOD to the hindlimb vascular bed in angiotensin II-treated mice. Mice were 
treated for 2 weeks with Ang II (100 ng • kg-1 • rain-l) or saline infusion. In Ang It-treated 
mice, mean blood pressure was significantly higher when compared to saline-infused 
mice (P<0.05). In aorta and femoral arteries from Ang II-treated mice, lucigenin- 
enhanced chemiluminescence demonstrated a 3-fold increase in superoxide levels, and 
the oxidative fluorescent probe hydroethidine indicated increased superoxide levels 
throughout he vascular wall, especially in the endothelium and adventitia. Hindfimb 
vasodilator responses to the endothelium-dependent agonists acetylcholine, adrenom- 
edullin, and substance P were lower mice treated with angiotensin II when compared to 
saline treated mice. In contrast, endothelium-independent responses to sodium nitro- 
prusside, DENNO, and CGRP were similar in both treatment groups. In vivo gene-trans- 
fer to the hindlimb vascular bed with an edenoviral vector that expressed eNOS, or 
extrecellular SOD (ECSOD) resulted in reduced expression of superoxide and enhanced 
vasodilator responses to the endothelium-dependent vasodilators. In contrast, viral vec- 
tors encoding the reporter gene or copper zinc SOD (CuZnSOD) did not alter superoxide 
expression or vasodilator responses in Ang II-treated mice. These data suggest that 
9ene-transfer of eNOS and EcSOD, but not CuZNSOD, reduces expression of superox- 
ide and restored endothelium-dependent responses in the hindlimb of Ang II-treated 
mice 
1151-75 Family-Based Investigation of the Role of an Endothelial 
Nitric Oxide Synthase Gene Polymorphlsm in Coronary 
Artery Disease 
Mark S. Soence. Paul G. McGlinchey, Chris Patterson, Christine Belton, Gillian Murphy, 
Dorothy McMaster, Pascal P. McKeown, Royal Victoria Hospital, Beffast, United 
Kingdom, Queen's University Belfast, Belfast, United Kingdom. 
Background: Coronary artery disease (CAD) is a complex phenotype arising from the 
interaction of genetic and environmental factors. Nitric oxide (NO) is synthesised in 
endothelial cells from L-arginine and molecular oxygen through the catalytic activity of 
endothelial NO synthase (eNOS) and it is believed to have important atheroprotective 
effects. Functionally important variants of the eNOS (NOS 3) gene could influence indi- 
vidual susceptibility to atherosclerosis by altering the amount of NO generated by the 
endothelium. The G894T (Glu298-Asp) polymorphism of the NOS 3 gene has been 
investigated in several case control studies, with some groups reporting that individuals 
carrying the T aflele are at increased risk of CAD but other groups have not confirmed 
this. 
Aims: Given these conflicting results we have used a family based association test to 
investigate the presence of finkage disequilibrium between the G894T polymorphism of 
the NOS 3 gene and CAD, in a well-defined Irish population. 
Methods: A total of 501 individuals (189 families) were recruited comprising 29 trios 
(individual affected with premature CAD and both parents) and 266 discordant sibships 
(one sibling affected with premature CAD and one older unaffected sibling). Premature 
CAD in our population was defined as onset before the age of 55 years in males and 
before the age of 60 years in females. All were genotyped for the G894T polymorphism 
of the NOS 3 gene. The presence of linkage disequilibrium was investigated using the 
combined transmission disequilibrium test (TDT) / sib TDT. This test is unaffected by 
population admixture and is specifically designed for the investigation of complex dis- 
eases. We tested for excess transmission of the G or T allele to affected individuals. Only 
one discordant sibship or trio was inctuded from each family to ensure the analyses were 
a valid test of association. 
Results: There was no statistically significant excess transmission of either allele to 
affected individuals, (p=0.20). 
Conclusion: Using newly developed family-based association methods we have found 
no evidence that the G894T (Glu298-Asp) polymorphism of the NOS 3 gene is associ- 
ated with CAD in our study population. 
1151-76 Elevated Glucose Increases ADMA: Role of Oxidative 
Stress and DDAH 
Ken Y. Lin, Bing Y. Wang, Philip S. Tsao, John P. Cooke, Cardiovascular Medicine, 
Stanford University School of Medicine, Stanford, California. 
Background: An endogenous inhibitor of nitric oxide synthase, asymmetric dimethylargi- 
nine (ADMA) is elevated in diabetic patients. Oxidative stress is also a hallmark of diabe- 
tes mellitus. We sought to determine if elevated glucose increased ADMA by impairing 
the activity of the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which 
metabolizes ADMA to citrulline. We further determined if the dysfunction of DDAH was 
due to oxidative stress. 
Methods: Human microvessel endothelial cell lines were cultured in normal (5 mM D- 
glucose), or high glucose conditions (25 mM D-glucose); in some experiments, mannose 
(20mM), or polyethyleneglycol-conjugated superoxide dismutase (PEG-SOD, 22u/mL) 
were added. ADMA production was measured by HPLC; cGMP by ELISA; DDAH activity 
by ADMA turnover ate. 
Results: ADMA was significantly elevated in the high glucose condition (2.21±0.21 I~M/ 
107 cells; p < 0.05) as compared to cells cultured in normal concentration of glucose 
(1.44±0.14). Mannose (as an osmotic control) had no effect on ADMA levels. PEG-SOD 
reduced ADMA levels to baseline in the high glucose condition (1.32±0.20). Reflecting 
bioavailable nitric oxide, cGMP production was significantly less in cells exposed to high 
glucose (74.8±6.4 frnol/mg protein; p < 0.05) than cells cultured in normal glucose or 
mannose (95.8±4.5 or 91.3±3.2); PEG-SOD restored cGMP levels in the high glucose 
condition (101±3.7 fmoVmg protein). DDAH activity was significantly reduced in high glu- 
cose (31.5±5.1%; p < 0.05) and was restored by PEG-SOD addition (38.8±3.3%) to a 
level comparable to cells exposed to normal glucose or mannose (40.2_+3.8% and 
42.5+_2.6%, respectively). 
Conclusions: Hyperglycemia elevates oxidative stress, which impairs DDAH activity, 
causing an increase in ADMA to reduce nitric oxide synthesis. This observation repre- 
sents a new insight into diabetes-induced endothelial dysfunction. 
